HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shu-zhong Jiang Selected Research

Percutaneous Coronary Intervention

1/2013Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shu-zhong Jiang Research Topics

Disease

1ST Elevation Myocardial Infarction
01/2013
1Myocardial Infarction
01/2013
1No-Reflow Phenomenon
01/2013

Drug/Important Bio-Agent (IBA)

1Verapamil (Calan)FDA LinkGeneric
01/2013

Therapy/Procedure

1Stents
01/2013
1Percutaneous Coronary Intervention
01/2013